首页|抗凝血酶Ⅲ、脂蛋白相关磷脂酶A2与进展性脑梗死的关系

抗凝血酶Ⅲ、脂蛋白相关磷脂酶A2与进展性脑梗死的关系

Correlation between antithrombin Ⅲ,serum lipoprotein-associated phospholipase A2 and progressive cerebral infarction

扫码查看
目的 探讨血浆抗凝血酶Ⅲ(AT-Ⅲ)活性、血清脂蛋白相关磷脂酶A2(Lp-PLA2)水平与进展性脑梗死的关系.方法 选取2018年1月至2019年6月金华市中心医院收治的95例脑梗死患者为研究对象,其中进展性脑梗死47例为观察组,非进展性脑梗死48例为对照组;选取同期本院健康体检的45名志愿者为健康组.比较3组研究对象治疗前以及观察组治疗前后血浆AT-Ⅲ活性、血清Lp-PLA2水平及美国国立卫生研究院卒中量表(NIHSS)评分,采用Pearson相关分析观察组治疗前血浆AT-Ⅲ活性、血清Lp-PLA2水平与NIHSS评分的相关性.结果 观察组治疗前血浆AT-Ⅲ活性均明显低于对照组和健康组(均P<0.05),血清Lp-PLA2水平均明显高于对照组和健康组(均P<0.05);而对照组血浆AT-Ⅲ活性明显低于健康组(P<0.05),血清Lp-PLA2水平明显高于健康组(P<0.05).观察组治疗第3、5、7天血浆AT-Ⅲ活性较治疗前明显降低(均P<0.05),而血清Lp-PLA2水平及NIHSS评分较治疗前均明显升高(均P<0.05);与治疗第 5天比较,治疗第 7 天血浆AT-Ⅲ活性明显升高(P<0.05),而血清Lp-PLA2水平及NIHSS评分均明显降低(均P<0.05).观察组治疗前血浆AT-Ⅲ活性与NIHSS评分呈负相关(r=-0.524,P<0.001),血清Lp-PLA2水平与NIHSS评分呈正相关(r=0.487,P<0.001).结论 血浆AT-Ⅲ活性、血清Lp-PLA2水平与进展性脑梗死患者病情发展及神经功能损害密切相关.
Objective To observe correlation between activity of plasma antithrombin-Ⅲ (AT-Ⅲ ),serum lipopro-tein-associated phospholipase A2(Lp-PLA2)level and progressive cerebral infarction(PCI).Methods Ninety-five patients with cerebral infarction admitted to Jinhua Central Hospital from January 2018 to June 2019 were included,including 47 cases with PCI(observation group)and 48 cases with non-PCI(control group).Forty-five volunteers who underwent health examinations in our hospital at the same time were selected as the healthy group.The activity of AT-Ⅲ ,serum Lp-PLA2,and the National Institutes of Health stroke scale(NIHSS)scores before treatment in three groups,before and after treatment in the observation group were compared.The correlation between the activity of AT-Ⅲ ,serum Lp-PLA2 levels,and NIHSS scores in the observation group before treatment were analyzed by Pearson correlation analysis.Results The activity of plasma AT-Ⅲ in the observation group was significantly lower than that in the control group and healthy group(all P<0.05),while serum Lp-PLA2 was significantly higher than that in the control group and healthy group(all P<0.05).The activity of plasma AT-Ⅲ in the control group was significantly lower than that in the healthy group(P<0.05),and the serum Lp-PLA2 was significantly higher than that in the healthy group(P<0.05).Compared with before treatment,on the 3rd,5th,and 7th day after treatment,plasma AT-III activity significantly decreased(all P<0.05),while serum Lp-PLA2 and NIHSS scores significantly increased(all P<0.05).Compared with the 5th day of treatment,the activity of plasma AT-Ⅲ was significantly higher on the 7th day of treatment(P<0.05),while Lp-PLA2 level and NIHSS score were significantly lower(all P<0.05).The activity of plasma AT-Ⅲ before treatment in the observation group was negatively correlated with NIHSS score(r=-0.524,P<0.001).The serum Lp PLA2 was positively correlated with NIHSS score(r=0.487,P<0.001).Conclusion Plasma AT-Ⅲ activity and serum Lp-PLA2 are closely related to PCI development and neurological impairment.

Progressive cerebral infarctionAntithrombin-ⅢLipoprotein-associated phospholipase A2Nerve functionCorrelation analysis

朱珊、王玉、胡益飞

展开 >

321000 金华市中心医院检验科

进展性脑梗死 抗凝血酶Ⅲ 脂蛋白相关磷脂酶A2 神经功能 相关性分析

2024

心电与循环
浙江省医学会

心电与循环

影响因子:0.269
ISSN:2095-3933
年,卷(期):2024.43(2)
  • 15